Skip to main content
. Author manuscript; available in PMC: 2015 Jul 6.
Published in final edited form as: J Alzheimers Dis. 2006 Dec;10(4):379–390. doi: 10.3233/jad-2006-10406

Table 2.

Viable cell counts for cells treated with either 2B12 or an irrelevant IgG, both at 10μg/ml, expressed as a percentage of cell counts of controls (growth media alone). Counts were performed after incubations lasting from 3 hours to 6 days. No significant differences (p<0.05) from control were detected in two-tailed Student’s t tests, n=3-4.

Incubation period
(days)
Antibody % no. of cells
(+/− 1 SEM)
MOG
3 hrs 2B12 81.2 +/− 7.1
6 hrs 2B12 145.4 +/− 38.4
1 day 2B12 78.1 +/− 15.8
2 days 2B12 79.7 +/− 7.8
3 days 2B12 81.3 +/− 11.2
6 days 2B12 106.1 +/− 3.9
4 days IgG 94.8 +/− 21.9

SY5Y
3 hrs 2B12 109.9 +/− 9.3
6 hrs 2B12 86.7 +/− 16.4
1 day 2B12 129.7 +/− 12.0
2 days 2B12 96.1 +/− 12.2
3 days 2B12 130.2 +/− 17.2
6 days 2B12 103.0 +/− 13.7
4 days IgG 83.2 +/− 6.8